Dopamine and acetylcholine are often discussed as if they operate on separate tracks in the brain, but they are locked in a constant, intricate conversation. In the striatum, a central hub for movement, motivation, and learning, these two chemicals directly regulate each other’s release, creating a balance that shapes nearly everything from how you learn new associations to how smoothly you move. When that balance tips, the consequences can be severe, showing up in conditions like Parkinson’s disease and schizophrenia.
How Acetylcholine Controls Dopamine Release
The most direct interaction between these two systems happens at the level of nerve terminals in the striatum, a large structure deep in the brain that acts as a gateway for voluntary movement and reward processing. Acetylcholine released by a specialized group of local neurons, called cholinergic interneurons, lands on receptors sitting right on dopamine-releasing terminals. These receptors come in two broad families, and each one pulls dopamine signaling in a different direction.
Nicotinic receptors, the same family that nicotine from cigarettes activates, can trigger dopamine release directly. Research on rat striatal tissue has shown that dopamine release through this route depends on receptors containing a specific subunit (called beta2), while other nicotinic receptor types boost dopamine indirectly by first releasing glutamate from nearby terminals.1PubMed. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum This means acetylcholine has at least two separate levers it can pull to increase dopamine output in the same brain region.
Muscarinic receptors add another layer. One subtype, called M5, sits on dopamine neuron terminals and directly enhances dopamine release. But two other subtypes, M2 and M4, act as brakes: they sit on cholinergic interneurons themselves and reduce acetylcholine output, which in turn dials down the nicotinic-receptor-driven dopamine release described above.2PubMed Central. Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens The net effect is a push-and-pull system where acetylcholine can both amplify and dampen dopamine signaling depending on which receptor type is activated.
The Glutamate Twist
Cholinergic interneurons in the striatum do something unusual: they release glutamate alongside acetylcholine. This dual-transmitter ability depends on a protein called vesicular glutamate transporter 3 (VGLUT3), which loads glutamate into the same vesicles that carry acetylcholine. Losing VGLUT3 does not just eliminate the glutamate signal; it also weakens acetylcholine signaling itself, because glutamate loading appears to help pack more acetylcholine into each vesicle.3PubMed Central. Striatal cholinergic neurotransmission requires VGLUT3
Experiments in genetically modified mice have teased apart what each transmitter from these interneurons actually does to dopamine. Mice lacking the ability to release acetylcholine from cholinergic interneurons showed a weaker burst of dopamine in response to a reward. Mice lacking glutamate release from those same neurons, by contrast, showed dopamine signals that lingered longer than normal. When both transmitters were knocked out, the dopamine response was a hybrid: lower peak height (like the acetylcholine-deficient mice) but a prolonged tail (like the glutamate-deficient mice).4PubMed Central. Functional dissociation of behavioral effects from acetylcholine and glutamate released from cholinergic striatal interneurons The upshot is that acetylcholine and glutamate from the same cells sculpt the timing and strength of dopamine signals in distinct, complementary ways.
Acetylcholine Waves and the Pause Response
Acetylcholine in the striatum does not just trickle out at a steady rate. Imaging studies in mice have captured acetylcholine being released in traveling waves that sweep across the striatum roughly once every five seconds, last about 400 milliseconds each, and move predominantly from the outer edge inward.5PubMed Central. Acetylcholine waves and dopamine release in the striatum These waves set up a rhythmic backdrop against which dopamine signals are read. When a wave of acetylcholine hits dopamine terminals, it can gate whether an incoming dopamine burst gets amplified or suppressed, depending on the timing.
Cholinergic interneurons are also known for a characteristic “pause” in their firing when something unexpected or rewarding happens. This brief silence in acetylcholine output appears to be just as important as the active release. Research has shown that the pause is driven by a specific potassium current triggered after the neuron receives excitatory input from the thalamus, and that dopamine itself tunes the pause through D2 receptors, which promote it, and D5 receptors, which suppress it.6eLife. Striatal cholinergic interneuron pause response requires Kv1 channels, is absent in dyskinetic mice, and is restored by dopamine D5 receptor inverse agonism So dopamine shapes the very acetylcholine signal that in turn shapes dopamine release. It is a feedback loop where each transmitter continuously tunes the other.
Where the Conversation Starts in the Midbrain
The striatal interaction gets most of the attention, but the dopamine-acetylcholine relationship actually begins one step earlier, in the brainstem. Two clusters of cholinergic neurons, the pedunculopontine nucleus and the laterodorsal tegmental nucleus, send projections upward into the midbrain, landing directly on the dopamine-producing cells of the substantia nigra and ventral tegmental area. By activating acetylcholine receptors on those dopamine neurons, these brainstem inputs influence how and when dopamine cells fire, effectively setting the gain on the entire dopamine system before dopamine even reaches the striatum.7PubMed Central. Cholinergic modulation of midbrain dopaminergic systems
This is also where nicotine exerts much of its effect. Nicotine acts as a mimic of acetylcholine at nicotinic receptors, and both the brainstem-to-midbrain pathway and the local cholinergic interneuron pathway in the striatum are targets for nicotine’s dopamine-boosting action.1PubMed. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum The reinforcing, habit-forming properties of smoking are in large part a story about nicotine hijacking the acetylcholine-dopamine interface at multiple levels of the brain simultaneously.
Learning, Prediction, and Salience
Dopamine’s role in learning is well established: bursts of dopamine in the nucleus accumbens signal prediction errors, the difference between what you expected and what you got. But prediction error alone is not enough. The brain also needs to decide how fast to update its beliefs, and that learning rate is governed by something called salience, which reflects how attention-grabbing or surprising a stimulus is. Recent work suggests that acetylcholine provides exactly this salience signal.
Recordings of acetylcholine dynamics in the nucleus accumbens during learning tasks found that acetylcholine levels tracked what computational models call “associative salience,” a measure of how much attention should be paid to a cue based on its history of predicting outcomes. The researchers concluded that dopamine and acetylcholine act as complementary signals in the same brain region: dopamine tells you what to learn, and acetylcholine tells you how much to learn at any given moment.8PubMed Central. Accumbal acetylcholine signals associative salience during learning This division of labor makes the two transmitters far more than simple “feel-good” and “attention” chemicals.
Acetylcholine’s contributions to cognition extend beyond learning rate. It is a critical modulator of sensory and association cortices. Prior animal studies have demonstrated that stimulating the brain’s main source of cortical acetylcholine, a structure called the nucleus basalis of Meynert, improves performance on visual working memory tasks to a degree comparable to cholinesterase-inhibitor drugs, the same class of medication used in Alzheimer’s treatment.9PubMed Central. Improving Visual Working Memory with Cholinergic Deep Brain Stimulation This finding underscores that while dopamine dominates discussions of motivation and reward, acetylcholine is carrying a heavy load in the cognitive processing that happens alongside it.
Habits and Flexible Behavior
One of the more striking consequences of disrupting the acetylcholine-dopamine balance shows up in the formation of habits. The dorsal striatum contains two functionally distinct compartments: a medial part involved in goal-directed, flexible behavior, and a lateral part associated with automatic habits. Acetylcholine from cholinergic interneurons helps keep the balance between these two modes.
Mouse studies in which acetylcholine release was selectively eliminated in the dorsomedial striatum found that dopamine release dropped in that same region but remained normal in the dorsolateral striatum. This imbalance pushed the animals toward habitual, inflexible behavior, including maladaptive eating patterns that resembled binge eating. Treating the mice with either a cholinesterase inhibitor (which boosts remaining acetylcholine) or L-DOPA (which boosts dopamine) corrected the behavior, confirming that the problem was a combined acetylcholine-dopamine deficit.10JCI Insight. Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating The implication for humans is that disruptions in striatal acetylcholine could contribute to compulsive or habitual behaviors, not because dopamine alone is dysfunctional, but because acetylcholine is no longer keeping dopamine appropriately distributed across the striatal landscape.
When the Balance Breaks in Parkinson’s Disease
The clinical condition that most clearly illustrates the dopamine-acetylcholine relationship is Parkinson’s disease. As dopamine-producing neurons in the substantia nigra degenerate, the striatum loses its dopamine supply. But the cholinergic interneurons remain largely intact and actually become overactive, leading to elevated acetylcholine levels.11Frontiers in Synaptic Neuroscience. Synaptic determinants of cholinergic interneurons hyperactivity during parkinsonism The result is a double hit: too little dopamine and too much acetylcholine.
This is why anticholinergic drugs were among the earliest treatments for Parkinson’s, long before L-DOPA was developed. By reducing acetylcholine activity, they partially restored the ratio between the two transmitters, easing symptoms like tremor and rigidity. Modern treatment still sometimes includes anticholinergics as an adjunct, though their side effects on memory and cognition (which depend heavily on acetylcholine in other brain regions) limit their use. The disease also disrupts the cholinergic interneuron pause response, which may help explain the involuntary movements (dyskinesias) that develop in some patients receiving long-term dopamine-replacement therapy.6eLife. Striatal cholinergic interneuron pause response requires Kv1 channels, is absent in dyskinetic mice, and is restored by dopamine D5 receptor inverse agonism
Muscarinic Receptors and Schizophrenia
The dopamine-acetylcholine interface is also central to newer thinking about schizophrenia. The classic dopamine hypothesis holds that psychotic symptoms arise from excessive dopamine activity in certain brain pathways. Muscarinic acetylcholine receptors, especially the M4 subtype, have emerged as key regulators of that dopaminergic overactivity. Preclinical research identified compounds that selectively boost M4 receptor function, and these compounds showed effectiveness in animal models used to predict antipsychotic drug activity.12PubMed Central. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
This line of research eventually led to the FDA approval of xanomeline-trospium (sold as Cobenfy) in 2024, the first muscarinic-targeted antipsychotic. Rather than blocking dopamine receptors directly, as every previous antipsychotic does, it works by activating muscarinic receptors that restrain dopamine release. The concept is a direct product of understanding the acetylcholine-dopamine relationship: instead of slamming the brakes on dopamine everywhere in the brain, you adjust the acetylcholine input that tunes dopamine locally where it matters. Early clinical results suggest fewer of the movement-related side effects that plague traditional dopamine-blocking antipsychotics, precisely because the approach works through the natural regulatory system rather than around it.
Dopamine and Acetylcholine in Sleep
The interplay extends beyond waking cognition into the regulation of sleep stages. Rapid eye movement (REM) sleep, the stage associated with vivid dreaming, depends on inputs from both dopamine and acetylcholine converging on the amygdala. In rat experiments, injecting a dopamine agonist or an acetylcholine agonist into the amygdala both increased REM sleep, while blocking either transmitter with an antagonist reduced it. Electrically stimulating the dopaminergic substantia nigra or the cholinergic pedunculopontine tegmentum also increased REM sleep, but only if the corresponding receptor in the amygdala was not blocked.13PubMed Central. Dopaminergic- and cholinergic-inputs from substantia nigra and pedunculo-pontine tegmentum, respectively, converge in amygdala to modulate rapid eye movement sleep in rats The two systems appear to integrate in the amygdala specifically for REM regulation, with neither one sufficient on its own.
This has practical implications for people taking medications that affect either system. Anticholinergic drugs are notorious for disrupting sleep architecture, and dopaminergic medications used in Parkinson’s disease can cause vivid dreams or REM sleep behavior disorder. Both effects become more understandable once you appreciate that REM sleep depends on a precise dopamine-acetylcholine balance that medications inevitably disturb.
An Ancient Partnership
One reason the dopamine-acetylcholine relationship is so deeply embedded in brain function may be that it is extremely old in evolutionary terms. Studies on planaria, simple flatworms with rudimentary nervous systems that diverged from the vertebrate lineage hundreds of millions of years ago, have found evidence of functional interactions between cholinergic and dopaminergic systems.14PubMed. Acetylcholine/dopamine interaction in planaria Even in invertebrates as distant as boxer shrimps, transcriptomic research has identified a reliance on dopamine and acetylcholine in regulating aggressive social behavior, suggesting diverse evolutionary paths in how these transmitters are deployed but a consistent theme of their co-involvement.15PubMed Central. Transcriptomic investigation of agonistic behaviors of boxer shrimps (Stenopus species)
The fact that these two transmitters have been talking to each other since before brains as we know them existed suggests that the relationship is not an accident of mammalian brain wiring. It is a fundamental organizing principle of nervous systems, one that vertebrates elaborated into the rich, multi-layered circuitry described in the sections above. The human striatum, with its cholinergic interneurons finely tuning dopamine signals to enable everything from smooth movement to flexible decision-making, represents one highly specialized version of a partnership that flatworms were already running in simpler form.